Back to Authors

Feng, Changyong

https://orcid.org/0000-0002-4432-1565

A5089845667 | I28792581

Mayo Clinic

University of Rochester Medicine

Citations 1

Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer

Cancer Biomarkers | January 31, 2017 | Volume: 7 | Issue: 2 | Pages: 101-108

10.3233/cbm-2010-0152 | PMID 21178268